Influence of pharmacists expertise on physicians prescription decisions by Murshid, Mohsen Ali et al.
Murshid et al 
Trop J Pharm Res, July 2016; 15(7): 1549  
 
Tropical Journal of Pharmaceutical Research July 2016; 15 (7): 1549-1557 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v15i7.27 
Original Research Article 
 
 
Influence of pharmacists expertise on physicians 
prescription decisions 
 
Mohsen Ali Murshid*, Zurina Mohaidin and Goh Yen Nee 
Graduate School of Business, Universiti Sains Malaysia, 11800 Penang, Malaysia 
 
*For correspondence: Email: mohsen092@gmail.com, Tel: +60-19-437-5620 
 
Received:         Revised accepted: 20 April 2016 
 
Abstract 
Purpose: To explore the influence of pharmacist factors on prescription decisions of physicians.   
Methods: A survey of literature was carried out across online databases and 12 relevant articles were 
identified. The influence of pharmacist factors on physician prescription decisions was identified in the 
articles. A conceptual model for investigating pharmacist factors that influence physicians’ prescription 
decisions was then developed. 
Results: The main factors identified were pharmacist expertise, pharmacist – physician collaboration, 
and trust between physician and pharmacist. There was no direct evidence of influence of pharmacist 
expertise on prescription, but some studies indicated that pharmacist recommendation is in tandem with 
the prescribing behaviour of physicians. One study reported that pharmacist–physician collaboration 
positively influenced physicians’ prescribing decision, while others found no relationship between these.  
Conclusion: Existing literature on the influence of pharmacist factors on prescription behaviour of 
physicians are limited and debatable. There is no consistency in these studies. Moreover, studies that 
reported a strong connection between the trustworthiness and pharmacist–physician collaboration in 
drug prescription lack hard evidence.  
 
Keywords: Physician prescription behaviour, Pharmacist factor, Collaboration, Trustworthiness 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




In recent years, the role of the pharmacist has 
turned from that of a dispenser to that of an 
influencer [1] and an active participant in 
decision–making during drug therapy [2].The 
report of WHO in 1997 highlighted new roles of 
the pharmacist as “as a caregiver, manager, 
decision–maker, leader, communicator, lifelong 
learner, and teacher” [1]. Over the years, the 
pharmacist’s role has expanded to include 
opinion giving and consultations [3,4]. 
Nonetheless, these additional roles are often not 
well developed in developing countries [1] such 
as Yemen, where pharmacists play a major role 
in drug prescription [5]. Pharmacists generally 
provide information relating to drug prescription, 
which can often be difficult to source in 
developing nations [2]. Given this role, 
pharmacists have become important targets for 
marketing tools of pharmaceutical firms [6]. 
 
The expertise of pharmacists makes them the 
most important source of knowledge on 
prescription decision-making [2,5,7], especially 
on drug interactions [1] and the movement of 
products of various competitors [8,9]. Evidence 
suggests that physicians are more likely to 
accept a pharmacist’s recommendations 
regarding the prescription of a particular drug, in 
Murshid et al 
Trop J Pharm Res, July 2016; 15(7): 1550  
 
terms of potency and economic viability [10,11]. 
The advice provided to physicians can be related 
to the pharmacist’s knowledge and experience 
regarding drug–related issues observed daily in 
the community [12]. 
 
Irrational prescription is a global health problem 
with the potential of harming both the individual 
and society [13].This issue makes a logical 
ground for pharmacists to influence physician 
prescriptions for improved patient outcome [4]. 
Unfortunately, poor collaboration between 
physicians and pharmacists has been recognized 
as a significant contributor towards inappropriate 
prescriptions [1]. This underscores the need for 
improved cooperation for optimal patient care 
[14]. Evidence suggests that collaboration 
between physicians and pharmacists improves 
medication safety and proper prescription [15]. 
There is good empirical evidence to show that 
trust is the key driver for improving the 
physician–pharmacist collaboration, for optimal 
prescription [11,16-19].  
 
The pharmacist’s key role in drug prescription 
practice often enhances overall patient outcomes 
[20,21] and the effect of a pharmacist on 
prescribing practices can undoubtedly be seen 
often daily in medication dispensing [2]. 
However, most attempts to explain prescription 
decision-making have been based on information 
processing [22], which takes into consideration 
drug and patient characteristics [23,24] in 
addition to the influence of marketing promotion 
techniques [25,26], while overlooking the 
influence of pharmacist factors [27]. The 
expertise of pharmacists as well as their 
collaboration with physicians may be important 
factors that influence physician’s drug 
prescription decision [12]. This fact is supported 
by studies which reported that community 
pharmacists routinely intervene to influence 
prescription decisions [2,7,19,28,29]. However, 
only a few studies have directly addressed the 
pharmacist’s ability to make such impacts. 
 
Previous reviews have been relatively discrete, 
or at most only partially assessed the 
collaboration between physicians and 
pharmacists (theoretical models) [16]. Therefore, 
the objectives of this review are: (1) to search 
existing literature for an understanding of the 
pharmacist factors (such as expert power of 
pharmacist, collaboration and trustworthiness 
between the pharmacist and physician) that 
influence physicians’ prescription decisions and 
(2) to explore the theoretical foundations of the 
effect of pharmacist factors on physician 




Searches for scientific articles were conducted 
using GoogleScholar, Sociological Abstracts, 
ScienceDirect, and PubMed online databases. 
Searches were restricted to articles published 
from 2001 to June 2015. Key phrases inputted in 
search engines included ‘factors influencing 
physician prescribing’, ‘effect of the pharmacist in 
prescribing’, ‘collaboration between physician 
and pharmacist’, ‘the influence of physician – 
pharmacist collaboration on prescribing’, 
‘pharmacist recommendation’,  and ‘expert 
power. A total of 12 articles were finally included 
in this review and these were reports of studies 
conducted in the USA (five articles), Netherlands 
(one article), Australia (three articles), France 





Table 1 shows characteristics of studies included 
in this review. A careful review of the content of 
the research articles reveals three main 
pharmacist factors found to be influencing 
physician decision to prescribe drugs: pharmacist 
expert power, pharmacist – physician 
collaboration, and trust between the physician 
and the pharmacist. 
 
Expert power of pharmacist and prescribing 
decision  
 
The expertise of the pharmacist has its roots in 
the social power theory. This theory originated 
from French and Raven [33] who tried to explain 
the sources of power individuals use to influence 
others. Power itself is known as the potential for 
influence [34].  Social power is the ability of a 
person or group to cause another person or 
group to change their attitudes or behaviours in 
the direction intended by the influencer [35].  
French and Raven [33] summarized five bases of 
the sources of the social power in which an 
individual may have power like expert power, 
reward power, referent power, legitimate power, 
and coercive power. Expert power is based on 
the “influence’s perception that the influencer has 
some special knowledge, information, or skills in 
a relevant area” [35].  It may be recognized that a 
pharmacist possesses itemized knowledge, 
information, skill, confidence, and power to 
control outcomes of the drug [1,36]. 
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Table 1: Characteristics of studies reviewed 
 
Theme of research Author 
(Country) 
 Study design Results 
Develop and validate the 
collaboration instrument for 
pharmacist 
Van et al  [30] 
(Australia) 
 Cross–sectional study utilized a 
questionnaire mailed to stratified 
sampling of  1215  pharmacists  
Communication and trust are the 
strongest influence on pharmacist –
physician collaboration 
Develop and validate the 
collaboration instrument for 
physician 
Van et al 
[15] 
(Australia) 
 Cross–sectional study utilised  a 
questionnaire mailed  to stratified 
sampling of1145 general 
practitioners(GPs) 
 
Interactional and practitioner 
determinants and the role of the 
pharmacist in medication were two 
predictors physician –pharmacist 
collaboration 







 Cross–sectional study utilised a 
questionnaire mailed to 1109 
specialists’ physicians. 
Physician– pharmacist 
collaboration improves physician 
prescribing  
Impact of the cooperation 
with pharmacists on 
prescribing 
Muijrers et al 
[12] 
(Netherland ) 
 Cross–sectional survey of 1434 
GPs were conducted 
The results show no measurable 
effects  between physicians – 
pharmacist cooperation and 
quality of prescribing 
Review on the 
collaboration between 
physician and pharmacist 
Bardet et al 
[16] 
(France) 
 An extensive literature search 
from 1990 to  June 2013 were 
conducted 
Interactional determinants such as 
trust and communication are the 
main drivers of physicians– 
pharmacist collaboration 
Factors that influence 
prescribing decisions 
Schumock et al 
[10] 
(USA) 
 Cross–sectional  study utilized  a 
telephone survey administered to 
150physicians, pharmacists and 
formulary committee members in 
community hospitals 
Pharmacist recommendations 
influence the physician prescribing 
decisions 
Pharmacists willingness to 
influence a physician’s 
decision 
Basak et al [4] 
(USA) 
 
Cross–sectional  study utilised  
an electronic link questionnaire 
administered to 243 pharmacists 
(who in a hospital pharmacy 
setting) 
Pharmacist expert power 
modulates the willingness of 




Moore et al [19] 
(Ireland) 
Cross–sectional study utilised  a 
questionnaire mailed  to 500 
GPs and  335 community 
pharmacists 
The results suggested that 
14% of pharmacists and 9% of 
physician felt that pharmacists 
have an influence on the 
prescribing behavior of a 
physician 
The expectations of GPs 
and pharmacists around 
collaboration 





through purposive sampling was 
conducted with 17 GPs and  7 
community pharmacists 
Results showed a minimal 
collaboration between 
physicians and pharmacist in 
terms of the extent to which 
they engaged decision-making 
Collaborative care 
between pharmacists and 
physicians, 
Doucett et al [3] 
(USA) 
Cross–sectional  study utilised  
a questionnaire mailed  to a 
sample of 321 pharmacists 
Trustworthiness is the factor 
associated with the 
development of the 
pharmacist–physician 
collaboration 
Develop and validate the 
collaboration instrument 
for physicians 
Zillich et al [17] 
(USA) 
Cross– sectional survey of a 
random sample of 1000 
physicians was conducted. 




collaborative role in patient 
management 
Yilshal et al [32] 
(Nigeria) 
Cross–sectional  study utilised a 
self –administrated 
questionnaire administered to 32 
pharmacists, 60 physicians  and  
200 patients 
Trustworthiness is a key factor 
that promotes physicians – 
pharmacist collaboration 
Interactional determinants’ 
such as trust and 
communication was the 
strongest predictor of 
collaboration 
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In practice, pharmacists have been shown to 
have the expert power source such as 
knowledge of drugs [1] and information power 
(i.e., present information or evidence about 
drugs) when attempting to influence prescriptions 
[4]. A vast body of the research supports this 
perspective [4,12,37]. For example, the physician 
may have a little knowledge when it comes to 
decision – making on new drugs. Thus, some of 
them rely on advice or recommendation from 
pharmacists who have better information of on 
drugs [2,11]. Therefore, it is logical to assume 
that physicians readily comply with the 
recommendations of pharmacists relating to drug 
information because of their expertise.  
 
According to social power theory, during the 
physician–pharmacist interaction involving drugs, 
pharmacists’ perception that they have potential 
to influence the physicians may likely lead them 
to exert power in various strategic forms. 
Qualitative studies have documented that 
pharmacists in some cases use a number of 
strategies to influence physicians’ prescription 
decision, such as offering a certain percentage 
from the drug sales, obtaining clinic rental 
payment, and allowing the sale of their free 
samples [38]. One study revealed that most 
physicians expect pharmacists to be experts in 
drug prescribing and thus to serve as guides in 
the appropriate use of drugs [39]. Another study 
also analyzed the current status of pharmacist’s 
influence on drug prescription and found that 
such influence can be seen daily in any 
conceivable situation [2].  
 
It has also been found that 34 % of physicians 
consult pharmacists before prescribing drugs 
[37]. The advice provided to physicians by the 
pharmacist may be based on the pharmacist’s 
expertise and drug–related problems seen in the 
pharmacy on a day–to–day basis [12]. A cross-
sectional study on general practitioners (GPs)–
pharmacist relationship discovered that 37 % of 
GPs and 43 % of pharmacists accept that 
communication between the professionals was 
very good, while 14 % of GPs and 9 % of 
pharmacists felt that pharmacists have a 
significant influence on the prescribing behaviour 
of physicians [19]. Out three cross-sectional 
studies, one showed that recommendations from 
pharmacists can improve the quality of 
prescriptions. Physicians are often likely to 
accept these recommendations in some cases to 
resolve drug–related problems [11]. Many of 
these physicians implemented or attempted to 
implement 72.3 % of pharmacist recommend-
dations [40]. Pharmacist recommendations have 
also been reported to influence prescription of 
the physician in a study that investigated the 
opinions of physicians, formulary committee 
members and pharmacists [10]. 
 
Only one of the studies reviewed was conducted 
on pharmacist expert power, as defined by 
Basak et al [4]; the study examined the role of 
perceived impact on relationship quality on the 
willingness of hospital pharmacist to influence 
prescribing decisions based on off–label drugs. It 
concluded that pharmacist expert relative power 
modulates the willingness of a pharmacist to 
influence the physician prescribing. In general, 
the effect of pharmacist expert power on the 
physician prescribing has not been tested, but, it 
seems reasonable to assume that to a greater or 
lesser extent, pharmacist recommendation at the 
time of prescribing by physician often exists. 
 
Pharmacist – physician collaboration and 
prescribing decision 
 
The roles of the physician and pharmacist in the 
prescribing process are complementary [11]. 
One study suggested that collaboration between 
physicians and pharmacists is beneficial for 
better prescriptions [40]. In practice, cooperation 
between physicians and pharmacists emerged 
as a key influence on prescribing behavior 
[12,19]. As a result, governments and 
organizations of health care around the world 
invest significant resources to improving 
collaboration between these professionals [41]. 
 
Zwarenstein et al [41] defined collaboration as 
“the process in which different professional 
groups work together to positively impact 
healthcare.” This means that strong working 
relationships between pharmacists and 
physicians are needed to optimize patient care 
[21]. In other words, prescription decision making 
is an outcome of collaboration between the 
physician and the pharmacist [42]. One study 
revealed that the main reason for collaboration 
between physician and pharmacist was about 
prescriptions [43]. 
 
In order to better understand the physician–
pharmacist collaboration, it is reasonable to turn 
to the model of the collaboration working 
relationship (CWR). CWR model was derived 
from previous models of business relationships, 
interpersonal relationships, cooperation care 
from physician–pharmacist relationship [44] and 
trust between professionals [16]. CWR was first 
developed in 2001 by McDonough and Doucette 
[45] re–modelled by Bradley et al [46] and 
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recently by Van et al [15] who established 
Attitudes Toward Collaboration Instrument for 
general physicians (ATCI–GP) model. 
 
CWR also was developed by Zillich et al [17], 
who proposed that three constructs: participant 
characteristics, context characteristics, and 
exchange characteristics affect collaboration 
between physicians and pharmacists. In this 
model, exchange characteristics consisted of 
three constructs: role specification, relationship 
initiation and trustworthiness. Trustworthiness 
involved both the degree of bidirectional 
communication and the medical practitioner’s 
credibility and reliability. 
 
ATCI–GP model [15] was derived from Zillich et 
al model [17].  The model shows the factors that 
influence physician–pharmacist collaboration 
from the pharmacist’s perspective in the 
provision of healthcare in Australia. The factors 
include interactive determinants such as 
communication, trust, a willingness to work 
together, and mutual respect. These factors 
directly influence pharmacist–physician 
collaboration. An important feature of this model 
is its suitability for measurement from physician 
to pharmacist. The model also may be a useful 
tool in determining the extent of collaboration in 
current practice and will allow for empirical 
assessment of interventions targeted at 
enhancing pharmacist–physician collaboration. 
 
This paper focuses on trustworthiness as a 
moderator of the relationship between 
pharmacist–physician collaboration and 
physician prescription based on this model.  
 
There is a wide range of viewpoints amongst 
academics about pharmacist – physician 
collaboration. Physicians claim that quality of 
prescription is dependent on pharmacist 
collaboration and its synergistic effects [12]. 
Further support for this perception is given by the 
work of Yilshal & Noel [32], who noted that 
physician–pharmacist collaboration improves 
prescription quality through increase in the 
efficiency and safety of drugs. Five studies 
reported that when pharmacists have 
successfully collaborated with physicians in the 
drug therapy processes, patient outcomes and 
physician prescribing behaviour improved 
[18,32,47-49]. One study using statistical tests 
and multiple regression found a positive effect of 
the collaboration of pharmacist on physician 
prescription [18]. 
 
In contrast, three studies had mixed results: one 
study found no association between quality of 
prescription and cooperation of pharmacists with 
physicians [12]. It reported a gap between the 
potential and actual influence of the pharmacist 
cooperation on prescription. This study 
recommended further research into the optimal 
form of cooperation between physicians and 
pharmacists. A second study examined the 
expectations, experiences and perceptions of 
physicians and pharmacists about collaboration 
in the primary care setting. It found that there is a 
minimal collaboration between the physician and 
pharmacist [31]. A third study investigated the 
opinions of physicians and pharmacist on 
physician –pharmacist collaboration in patient 
therapy. The results indicated that no statistical 
difference on the need to encourage 
collaboration among respondents [32]. 
Furthermore, the respondents agreed that 
physician–pharmacist collaboration is necessary 
and should be encouraged. 
 
Trustworthiness between physician and 
pharmacist and prescribing decision 
 
Trustworthiness in this research is defined as a 
physician’s ability to trust a pharmacist’s word 
and expertise [17]. Trustworthiness is considered 
the main driver that improves and supports 
physician–pharmacist relationship [32]. A 2015 
review concluded that trustworthiness was an 
important factor in enhancing collaborative 
relationships between physicians and 
pharmacists [16].  Several studies indicated that 
trustworthiness strongly impacts on pharmacist–
physician collaboration, which in turn positively 
influences physician prescribing behaviour 
[3,17,44,46,50]. 
 
Other studies provide additional support for the 
influence of trustworthiness on pharmacist- 
physician collaboration [3,15,17].  One of these 
conducted by mailed survey showed that 
trustworthiness was positively associated with 
physician–pharmacist collaboration [17]. A 
second study in the same year investigated the 
factors associated with pharmacist–physician 
collaboration at baseline and at 3 months. The 
results indicated that trustworthiness was the 
strongest predictor of physician–pharmacist 
collaboration at these points [3]. A third and more 
recent, cross-sectional study found that 
trustworthiness (such as communication and 
trust) was the strongest factors influencing the 
pharmacist – physician collaboration [15]. 
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The collaboration of the pharmacist was found to 
have significant influence on physician 
prescribing behaviour. However, the magnitudes 
of effects reported vary considerably and in some 
cases even conflict. Thus a systematic research 
on the conditions under which this link is 
strengthened is lacking. The basic rationale for 
studying trustworthiness as moderator of this link 
is that the level of pharmacist–physician 
collaboration in prescribing practice depends on 
trustworthiness between professionals. 
 
For example, high level of trustworthiness 
ensures more collaboration because it stimulates 
cooperation between physician and pharmacist. 
There is a large empirical evidence showing that 
trustworthiness improves the collaboration 
process between physician and pharmacists and 
stimulates interaction, which in turn positively 
influences physician prescribing behaviour 
[3,17,18,31,50]. Since pharmacist-physician 
collaboration can affect prescription only if the 
physician considers it reliable, the level of 
physician’s trust in the pharmacist moderates the 




The evidence base for pharmacist factor 
influence on prescription by physicians is narrow, 
and based mainly on cross-sectional, self-
completed questionnaire studies, surveys and 
interviews. For example, studies exclusively 
based on pharmacist expert power are scanty, 
although available evidence suggests that 
pharmacist can influence physician prescribing 
behaviour [1,2,7,28,29,38]. Some studies have 
shown that the influence of pharmacist–physician 
collaboration on prescribing behaviour is trivial 
and inconclusive. Moreover, the moderating 
impact of trustworthiness on the effect of 
pharmacist–physician collaboration upon 
prescribing remains unclear.  
 
The influence of the pharmacist expert power on 
physician prescribing decision has not been 
reported in detail. This review found no direct 
evidence of the influence pharmacist expert 
power on prescribing attitude, but some studies 
indicate that pharmacists’ recommendation or 
consultation is in tandem with the prescribing 
behaviour of physicians [10-12]. Social power 
theory provides theoretical support for this 
relationship. According to this theory, the key 
mechanism leading to a change in behaviour is 
that one person (B) has the expert power to 
influence the other person (A) in order to change 
his or her behaviour. Logically, it is expected that 
a pharmacist will take this active role in 
influencing prescription behaviour since 
physicians are likely to rely on advice or 
recommendations from pharmacists who have 
more information, knowledge, confidence and 
power to control [4,12,37]. 
 
Theoretically, pharmacist – physician 
collaboration may improve the physician 
prescribing decisions and thus enhance patient 
outcome. However, some of studies have shown 
that the influence of pharmacist–physician 
collaboration on prescribing behaviour is 
insignificant and unconvincing. For example, 
some studies found no relationship between 
these two [12], while others reported a small 
effect [18]. This may be due to the fact that the 
current level of cooperation between the 
physician and pharmacist in the prescribing 
process is weak [31]. Moreover, these studies 
are narrowly focused and so may be regarded as 
partial assessments of the relationship between 
pharmacist – physician collaboration and 
prescribing quality. 
 
On the other hand, given the reported weak 
relationship between the pharmacist 
collaboration and physician prescribing 
behaviour, this paper posits that trustworthiness 
is a potential tool for strengthening this 
collaboration. Thus, the response of physicians 
to pharmacist intervention possibly modulates 
their prescribing behaviour. The review proposes 
that trustworthiness has a bearing on the 
influence of pharmacist – physician collaboration 
on physician prescribing behaviour [3,15,17]. 
 
Proposed model for further research 
 
A theoretical model of pharmacist – physician 
interplay on prescription based on the pharmacist 
factors enumerated in the present review, is 
shown in Figure 1. The proposal model has four 
major constructs. The model includes factors 
discussed in this review such as pharmacist 
expert power and pharmacist – physician 
collaboration that may affect directly physician 
decision   to   prescribe   drugs. The   theoretical  
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Figure 1: Proposed model of pharmacist – physician collaboration in prescription 
 
model is also an approach towards recognizing 
trustworthiness as a variable that may moderate 
the relationship between pharmacist-physician 
collaboration and prescribing behaviour. 
Nonetheless, the study recommends further 
research on the influence of each factor on 
physician prescribing behaviour and an 





The body of evidence on the pharmacist factors 
that influence physician’s decision to prescribe 
drugs is relatively small. In theory, pharmacist’s 
expertise and collaboration with physicians affect 
prescription decision and may also influence 
patient health by improving the quality and 
rational of prescription. However, in this review, 
we have found little evidence to support this. 
There is still a need to understand in relation to 
how pharmacist factors affect physician 
prescription behaviour.  
 
One clear finding from this review is the absence 
of evidence on impact of pharmacist – physician 
collaboration on prescription behaviour. Some of 
the studies argue that poor professional 
collaboration between the physician and 
pharmacist leads to increase in irrational 
prescriptions. This should be of concern for 
policy makers and managers of health care. The 
present review contributes to resolving the 
debate on the ways pharmacist – physician 
collaboration affect prescribing behaviour. More 
specifically, this research investigates the level to 
which the effects of pharmacist – physician 
collaboration on physician decision making may 
depend upon trustworthiness between the two 
professionals. Further empirical research to 
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